Skip to main content

Advertisement

SpringerLink
Log in

A Unique and As Yet Unexplored Subset of Metastatic Colorectal Cancer: Widespread Lymph-Node-Only Recurrence

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Desch CE, Benson 3rd AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23:8512.

    Article  PubMed  Google Scholar 

  2. National Comprehensive Cancer Network (NCCN) guidelines (2012) www.nccn.org. Accessed on 30 July 2012.

  3. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27:3379.

    Article  PubMed  Google Scholar 

  4. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979.

    PubMed  CAS  Google Scholar 

  5. McGory ML, Shekelle PG, Ko CY. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst. 2006;98:1623.

    Article  PubMed  Google Scholar 

  6. Redston M, Compton CC, Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol. 2006;24:878.

    Article  PubMed  Google Scholar 

  7. Lim SJ, Feig BW, Wang H, et al. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008;15:46.

    Article  PubMed  Google Scholar 

  8. Faerden AE, Sjo OH, Sjo O, et al. Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer. Dis Colon Rectum. 2008;51:891.

    Article  PubMed  Google Scholar 

  9. Cahill RA, Bembenek A, Sirop S, et al. Sentinel node biopsy for the individualization of surgical strategy for cure of early-stage colon cancer. Ann Surg Oncol. 2009;16:2170.

    Article  PubMed  Google Scholar 

  10. Fujie Y, Ikeda M, Seshimo I, et al. Complete response of highly advanced colon cancer with multiple lymph node metastases to irinotecan combined with UFT: report of a case. Surg Today. 2006;36:1133.

    Article  PubMed  Google Scholar 

  11. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg. 1995;130:1062–7.

    Article  PubMed  CAS  Google Scholar 

  12. Ohlsson B, Breland U, Ekberg H, et al. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum. 1995;38:619–26.

    Article  PubMed  CAS  Google Scholar 

  13. Kjeldsen BJ, Kronborg O, Fenger C, Jørgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997;84:666–9.

    Article  PubMed  CAS  Google Scholar 

  14. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survivalof colorectal cancer patients. Gastroenterology. 1998;114:7–14.

    Article  PubMed  CAS  Google Scholar 

  15. Pietra N, Sarli L, Costi R, et al. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum. 1998;41:1127–33.

    Article  PubMed  CAS  Google Scholar 

  16. Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002;28(4):418–23.

    Article  PubMed  Google Scholar 

  17. Galandiuk S, Wieand HS, Moertel CG, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1992;174:27–32.

    PubMed  CAS  Google Scholar 

  18. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2002;CD002200.

  19. Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324:813.

    Article  PubMed  Google Scholar 

  20. Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.

    Article  PubMed  Google Scholar 

  21. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278.

    PubMed  CAS  Google Scholar 

  22. Jamison RL, Donohue JH, Nagorney DM, et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 1997;132:505.

    Article  PubMed  CAS  Google Scholar 

  23. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309.

    Article  PubMed  CAS  Google Scholar 

  24. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818.

    Article  PubMed  Google Scholar 

  25. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240:438.

    Article  PubMed  Google Scholar 

  26. Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982.

    Article  PubMed  CAS  Google Scholar 

  27. Wei AC, Greig PD, Grant D, et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13:668.

    Article  PubMed  Google Scholar 

  28. Rees M, Tekkis PP, Welsh FK, et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125.

    Article  PubMed  Google Scholar 

  29. Morris EJ, Forman D, Thomas JD, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg. 2010;97:1110.

    Article  PubMed  CAS  Google Scholar 

  30. McAfee MK, Allen MS, Trastek VF, et al. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg. 1992;53:780.

    Article  PubMed  CAS  Google Scholar 

  31. Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg. 2002;124:1007.

    Article  PubMed  Google Scholar 

  32. Ike H, Shimada H, Ohki S, et al. Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum. 2002;45:468.

    Article  PubMed  Google Scholar 

  33. Rizk NP, Downey RJ. Resection of pulmonary metastases from colorectal cancer. Semin Thorac Cardiovasc Surg. 2002;14:29.

    Article  PubMed  Google Scholar 

  34. Glemelius B, Palman L, Graf W, et al. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol. 1992;10:904.

    Google Scholar 

  35. Ackland SP, Jones M, Tu D, et al. A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. Br J Cancer. 2005;93:1236.

    Article  PubMed  CAS  Google Scholar 

  36. Glimelius B, Graf W, Hoffman K, et al. General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy: a longitudinal study. Acta Oncol. 1992;31:645.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of Interest

All authors state that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, 6300 8th Avenue, Brooklyn, NY, 11220, USA

    Jay Lipshitz, Alan B. Astrow & Yiqing Xu

Authors
  1. Jay Lipshitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan B. Astrow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yiqing Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jay Lipshitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipshitz, J., Astrow, A.B. & Xu, Y. A Unique and As Yet Unexplored Subset of Metastatic Colorectal Cancer: Widespread Lymph-Node-Only Recurrence. J Gastrointest Canc 44, 466–471 (2013). https://doi.org/10.1007/s12029-012-9470-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-012-9470-6

Keywords

Search

Navigation